Genomic diagnostics company. Could be part of the genomic revolution.
Not so cheap anymore, high risk high reward
Komentarz
⋅
earnings tomorrow after close, looking to buy breakout 8.50 or support channel trendline
Komentarz
⋅
add more on breakout
Komentarz
⋅
Long sideways period but still holding and accumulated more of this stock. Adjusted channel.
Some news: "Veracyte Chairman and CEO Bonnie Anderson Receives Prestigious Innovation Award at Biomedical Engineering Society Annual Meeting- The Coulter Foundation’s Wallace H. Coulter Award for Healthcare Innovation Recognizes Excellence and Leadership in Clinical Diagnostic Medicine"